HPIVS Rapid Test

Dénomination commerciale

HPIVS Rapid Test

06974566303322

B-06974566303322

Numéro de référence/catalogue

RHP-602

GS1

IVDD — Général

Législation applicable

IVDD [Directive 98/79/CE relative aux dispositifs médicaux de diagnostic in vitro]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

This kit is used for in vitro qualitative detection of parainfluenza virus IgM antibodies in venous whole blood or serum (plasma) samples of infants and young children. Human Parainfluenza virus (HPIVS), HPIVS is a kind of pleomorphic, enveloped single-stranded negative-stranded RNA virus, is a paramyxovirus, divided into 4 subtypes, PIV-1 and PIV-3 belong to Respiratory viruses, while PIV-2 and PIV-4 belong to the mumps virus genus. The virus is 125-250 nm in diameter, and its envelope is composed of lipids and glycoproteins. There are two kinds of glycoproteins: one is hemagglutinin-neuraminidase protein (NH), which has hemagglutination activity and neuraminidase activity; the other is fusion protein (F protein), which has the effect of promoting cell fusion and hemolysis characteristic. PIV infection mainly causes lower respiratory tract infection in infants and young children. In adults, the main manifestation is upper respiratory tract infection. According to statistics, 30% to 40% of acute respiratory infections in infants and young children are caused by parainfluenza virus. About 33% of children with laryngitis and about 10% of lower respiratory tract infections are associated with parainfluenza virus, second only to respiratory syncytial virus and adenovirus infections. The clinical manifestations of PIV respiratory infection in adults are indistinguishable from other pathogens. In hospitalized adults, the most common clinical manifestations of HPIVS are cold-like symptoms, including cough, runny nose, and sore throat, and pneumonia is considered a common form of PIV infection in adults. In clinical practice, kits such as colloidal gold method, fluorescence immunochromatography and PCR method are used to detect parainfluenza virus. This kit is suitable for auxiliary diagnosis of human infection by parainfluenza virus in clinical practice.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• W0105040604INFLUENZA & PARA INFLUENZA